AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Amgen plans a publicly accessible webcast of its September 15, 2026 conference presentation, with replay available for at least 90 days.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amgen (AMGN) will present at the Morgan Stanley 24th Annual Global Healthcare Conference at 11:30 a.m. ET on Tuesday, September 15, 2026. Executive vice president Jay Bradner and executive vice president and chief financial officer Thomas Dittrich will speak at the event. A live webcast will be available to media, investors and the public via the Investors section of Amgen's website and will be archived for replay for at least 90 days.
Details
News Market Reaction – AMGN
On Sep 10, the first trading day after this news, AMGN closed 2.25% below the previous close. Relative volume reached 1.9x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 10 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-302874236.html
SOURCE Amgen
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How can investors and the public access Amgen's conference presentation?
The presentation will be webcast live over the internet and can be accessed through the Investors section of Amgen's website at www.amgen.com. Information on webcast availability and links is provided on Amgen's Investor Relations Events Calendar.
Who from Amgen will present at the Morgan Stanley 24th Annual Global Healthcare Conference?
Jay Bradner, executive vice president, Research and Development, Artificial Intelligence and Data, and Thomas Dittrich, executive vice president and chief financial officer, will present at the conference.
How long will the webcast replay of Amgen's presentation be available?
The webcast will be archived on Amgen's website and available for replay for at least 90 days after the event.